首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性肺心病患者血浆脑钠素前体水平及其意义
引用本文:李桂忠,侯嘉,叶伟,徐华,蒋维,庞永正,曹军,唐朝枢.慢性肺心病患者血浆脑钠素前体水平及其意义[J].放射免疫学杂志,2003,16(6):342-344.
作者姓名:李桂忠  侯嘉  叶伟  徐华  蒋维  庞永正  曹军  唐朝枢
作者单位:1. 宁夏医学院病理生理室,750004
2. 宁夏医学院附属医院呼吸内科
3. 宁夏干部疗养院,750004
4. 北京大学第一医院心血管病研究所,100034
基金项目:宁夏回族自治区卫生厅重点科研计划课题资助 ( 2 0 0 2 )第 42 5号
摘    要:目的 :选择慢性阻塞性肺疾患和慢性肺心病病人 ,探讨脑钠素前体 (proBNP1 -76)血浆水平与慢性肺心病之间的关系及其意义。方法 :放射免疫分析检测血浆 proBNP1 -76含量 (ng/L)。 结果 :慢性阻塞性肺疾患组的 proBNP1 -76浓度较正常对照组升高 (p <0 0 5 ) ,右下肺动脉横径、右室流出道内径较正常对照组显著增大 (p <0 0 0 1 ) ,右室前壁厚度与proBNP1 -76浓度存在正相关 (r =0 5 4 1 ,p <0 0 1 ) ;慢性肺心病组的proB NP1 -76浓度、右下肺动脉横径、右室流出道内径、右室前壁厚度较正常对照组和慢性阻塞性肺疾患组均显著升高 (p <0 0 0 1 ) ,右室流出道内径与 proBNP1 -76浓度水平存在正相关 (r =0 4 77,p <0 0 5 )。 结论 :测定血浆proBNP1 -76水平对于监测慢性肺心病的发生可以起到一个早期标志物的作用 ,对于临床早期诊断和预防慢性肺心病提供一个有意义的参考指标

关 键 词:脑钠素前体  慢性肺心病  放射免疫分析  早期诊断
修稿时间:2003年10月16

Significance of Changes of Levels of Plasma proBNP1-76 in Patients with Chronic Pulmonary Heart Disease
Li Guizhong ,Hou Jia ,Ye Wei ,Xu Hua ,Jiang Wei ,Pang Yongzheng ,Cao Jun ,Tang Chaoshu.Significance of Changes of Levels of Plasma proBNP1-76 in Patients with Chronic Pulmonary Heart Disease[J].Journal of Radioimmanology,2003,16(6):342-344.
Authors:Li Guizhong  Hou Jia  Ye Wei  Xu Hua  Jiang Wei  Pang Yongzheng  Cao Jun  Tang Chaoshu
Institution:Li Guizhong 1,Hou Jia 2,Ye Wei 3,Xu Hua 1,Jiang Wei 4,Pang Yongzheng 4,Cao Jun 1,Tang Chaoshu 4 1. Department of Pathophysiology,Ninxia Medical College
Abstract:Objective To investigate the significance of the changes levels of plasma proBNP 1-76 in patients with COPD and chronic pulmonary heart disease. Methods Plasma proBNP 1-76 levels were determined with radioimmunoassay in patients with CHPD ( n=23 ), COPD (n=24) and 32 controls. Results The concentrations of plasma proBNP 1-76 in patients with chronic obstructive pulmonary disease were significantly increased (vs controls, p <0 05), right inferior pulmonary artery diameter and right ventricle out flow tract diameter were also increased markedly ( p <0 001); right ventricle anterior wall thickness was positively correlated to the concentrations of plasma proBNP 1-76 ( r=0 541, p <0 01). The concentrations of plasma proBNP 1-76 , ritght inferior pulmonary artery diameter, right ventricle out flow tract diameter and right ventricle anterior wall thickness in patients with chronic pulmonary heart disease were increased significantly (vsCOPD patients and controls, p <0 001); right ventricle out flow tract diameter was positively correlated to the concentrations of plasma proBNP 1-76 ( r=0 477, p <0 05). Conclusion Plasma proBNP 1-76 is an early marker of right ventricular hypertrophy and right ventricular dysfunction, measurement of which is useful in the management of patients with chronic pulmonary heart disease in daily practice.
Keywords:proBNP    1-76    chronic pulmonary heart disease  radioimmunoassay
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号